Profile data is unavailable for this security.
About the company
Hunan Warrant Pharmaceutical Co Ltd is a China-based company mainly engaged in the research, development, production and sales of chemical raw materials, chemical drug preparations and traditional Chinese medicine preparations. The Company's products include various dosage forms such as tablets, capsules, granules, powders, dry suspensions, inhalation solutions, small volume injections, eye drops, freeze-dried powder injections and chemical raw materials. The products cover fields such as digestion, respiration and anti infection. The Company primarily distributes its products in domestic and overseas markets.
- Revenue in CNY (TTM)1.43bn
- Net income in CNY213.03m
- Incorporated2001
- Employees1.24k
- LocationHunan Warrant Pharmaceutical Co LtdBuilding C6-C7, Jinrui Lugu ScienceTechnology Park, No. 28 Lutian RoadCHANGSHA 410006ChinaCHN
- Phone+86 73 185910599
- Fax+86 73 185910568
- Websitehttps://www.warrant.com.cn
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hunan Fangsheng Pharmaceutical Co Ltd | 1.68bn | 295.36m | 5.30bn | 1.81k | 17.99 | 3.17 | -- | 3.15 | 0.6709 | 0.6709 | 3.83 | 3.81 | 0.5327 | 1.42 | 6.00 | 931,293.10 | 9.11 | 6.11 | 16.09 | 10.86 | 68.68 | 67.05 | 17.10 | 10.32 | 0.5475 | 19.04 | 0.2332 | 49.73 | 9.15 | 10.20 | 36.61 | 26.46 | -13.82 | 38.88 |
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.63bn | 250.04m | 5.53bn | 5.27k | 18.38 | 1.88 | -- | 1.52 | 0.6115 | 0.6115 | 8.87 | 5.98 | 0.7768 | 4.12 | 9.84 | 689,467.60 | 7.43 | 8.36 | 13.56 | 15.33 | 48.13 | 44.74 | 9.56 | 9.71 | 1.13 | -- | 0.0182 | 67.36 | -4.44 | 0.5863 | -27.98 | -4.75 | 3.10 | -6.36 |
| Hunan Warrant Pharmaceutical Co Ltd | 1.43bn | 213.03m | 5.63bn | 1.24k | 26.42 | 2.83 | -- | 3.94 | 1.62 | 1.62 | 10.89 | 15.17 | 0.554 | 1.40 | 7.99 | 1,154,661.00 | 7.61 | 9.47 | 8.79 | 11.61 | 59.10 | 67.03 | 13.74 | 13.01 | 3.03 | -- | 0.1503 | 14.11 | -1.38 | 11.37 | -22.24 | 7.21 | 57.23 | -- |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 957.76m | 241.67m | 5.70bn | 1.33k | 23.63 | 2.42 | -- | 5.95 | 1.21 | 1.21 | 4.79 | 11.82 | 0.3733 | 3.26 | 3.71 | 721,747.90 | 9.37 | 8.99 | 10.04 | 9.78 | 87.92 | 88.72 | 25.11 | 23.97 | 7.17 | -- | 0.0092 | 32.97 | 4.14 | 10.57 | 0.1095 | 14.20 | 42.01 | -- |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.60bn | -43.60m | 5.80bn | 1.39k | -- | 4.34 | -- | 2.23 | -0.1527 | -0.1527 | 9.10 | 4.68 | 0.7279 | 3.28 | 4.16 | 1,872,001.00 | -0.8081 | 5.51 | -1.74 | 10.75 | 36.36 | 51.36 | -1.11 | 7.34 | 0.7909 | 1.88 | 0.4592 | 30.61 | -0.6275 | 10.86 | -37.66 | 1.09 | 1.85 | 1.16 |
| ChengDu Sheng Nuo Biotec Co Ltd | 638.35m | 120.09m | 5.98bn | 1.38k | 49.86 | 5.79 | -- | 9.36 | 0.7615 | 0.7615 | 4.09 | 6.56 | 0.3714 | 0.973 | 4.28 | 462,238.30 | 6.98 | 6.05 | 10.10 | 7.75 | 55.34 | 66.00 | 18.80 | 14.91 | 0.9008 | 14.11 | 0.3862 | 26.83 | 4.84 | 6.90 | -28.88 | 0.7741 | 51.66 | -- |
Data as of Mar 03 2026. Currency figures normalised to Hunan Warrant Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
8.86%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 2.87m | 2.19% |
| Caitong Fund Management Co., Ltd.as of 30 Jun 2025 | 1.87m | 1.43% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2025 | 1.84m | 1.40% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2025 | 1.35m | 1.03% |
| Essence Fund Co., Ltd.as of 30 Jun 2025 | 1.23m | 0.94% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 947.55k | 0.72% |
| First-Trust Fund Management Co., Ltd.as of 30 Jun 2025 | 588.77k | 0.45% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2025 | 335.01k | 0.26% |
| China International Capital Corp. HK Asset Management Ltd.as of 30 Jun 2025 | 300.31k | 0.23% |
| Da Cheng Fund Management Co., Ltd.as of 30 Jun 2025 | 296.87k | 0.23% |
More ▼
Data from 30 Jun 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
